Adrenocortical Carcinoma
Top Cited Papers
Open Access
- 20 December 2013
- journal article
- review article
- Published by The Endocrine Society in Endocrine Reviews
- Vol. 35 (2), 282-326
- https://doi.org/10.1210/er.2013-1029
Abstract
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy, often with an unfavorable prognosis. Here we summarize the knowledge about diagnosis, epidemiology, pathophysiology, and therapy of ACC. Over recent years, multidisciplinary clinics have formed and the first international treatment trials have been conducted. This review focuses on evidence gained from recent basic science and clinical research and provides perspectives from the experience of a large multidisciplinary clinic dedicated to the care of patients with ACC.Keywords
This publication has 308 references indexed in Scilit:
- Targeting the Insulin Growth Factor Receptor 1Hematology/Oncology Clinics of North America, 2012
- Towards an understanding of the role of p53 in adrenocortical carcinogenesisMolecular and Cellular Endocrinology, 2012
- The microcosmos of cancerNature, 2012
- Pediatric adrenocortical tumors: morphological diagnostic criteria and immunohistochemical expression of matrix metalloproteinase type 2 and human leucocyte-associated antigen (HLA) class II antigens: Results from the Italian Pediatric Rare Tumor (TREP) Study projectHuman Pathology, 2012
- The Weiss Score and Beyond—Histopathology for Adrenocortical CarcinomaHormones and Cancer, 2011
- MicroRNA profiling of adrenocortical tumors reveals miR‐483 as a marker of malignancyCancer, 2010
- Embolization of Nonliver Visceral TumorsSeminars in Interventional Radiology, 2009
- Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinomaCancer Chemotherapy and Pharmacology, 2009
- Beckwith–Wiedemann syndromeEuropean Journal of Human Genetics, 2009
- Tumour-suppressor activity of H19 RNANature, 1993